Navigation Links


PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu

10/22/2014
Rock Hill, SC (PRWEB) October 22, 2014 Physicians Choice Laboratory Services (PCLS) announces the expansion of its cardiovascular pharmacogenetics menu, which enables healthcare providers to individualize therapeutic treatments for improved patient outcomes. With PCLS’s evidence-based results, healthcare providers are better able to assess patients’ individual needs and optimize their ther... [Comments]

Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets

10/22/2014
(PRWEB) October 22, 2014 According to new market research report "Cloud Professional Services Market by Service Type (Consulting, Integration, Deployment & Support), by Service Model (SaaS, PaaS, IaaS), and by Deployment Model (Public, Private, Others (Hybrid & Community)) - Global Forecast to 2019", published by MarketsandMarkets, defines and segments the Cloud Profession... [Comments]

Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program

10/22/2014
ROCKVILLE, Md. , Oct. 22, 2014   Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel pathogen-specific therapies for serious infections and diseases, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a composition of matter patent application that covers the lead product in its C. difficile... [Comments]

iCo Therapeutics Announces Advancement of Oral Amphotericin B Program

10/22/2014
VANCOUVER , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today announced next steps for its Oral Amphotericin B program.  The company recently announced positive findings from its in vitro work involving samples from HIV/AIDS patients exposed to HAART therapy.  iCo now plans to complete pre clinical studies and regulatory... [Comments]

Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc.

10/22/2014
NEW YORK , Oct. 22, 2014 Nuvilex, Inc. (OTCQB: NVLX) – According to the International Diabetes Federation, approximately 400 million people worldwide are living with diabetes, with  that number expected to grow to 552 million people by 2030.  The global market for diabetes treatments is approximately $500 billion.  In 2012 approximately 330,000 people w... [Comments]

Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020)

10/22/2014
DUBLIN , Oct. 22, 2014 Research and Markets  has announced the addition of the "Organic Electronics Market by Material, by Application, Geography - Global Analysis and Forecast (2014 - 2020)" report to their offering. Organic electronics, also called as polymer electronics or plastic electronics, is a branch of material science which deals with small conductive mole... [Comments]

aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research

10/22/2014
SAN DIEGO and HONG KONG , Oct. 22, 2014  aTyr Pharma ("aTyr"), an innovative rare disease therapeutics enterprise, announced today that rare disease expert John C. McKew , Ph.D., joined the company as vice president, research. Dr. McKew brings more than two decades of expertise in translational research, including key leadership positions at the National Institutes of... [Comments]

Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets

10/20/2014
(PRWEB) October 20, 2014 The report “Pharmacy Automation Systems Market by product type (Medication Dispensing Systems, Packaging and Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy Automation, Outpatient Pharmacy Automation) - Global Forecasts & Trends to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, A... [Comments]

Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production

10/20/2014
NEW YORK , Oct. 20, 2014 Mapp Biopharmaceutical's valiant effort to produce more of their experimental ZMapp™ antibody therapeutic to fight the Ebola outbreak will make the public aware of how difficult and time-consuming the production of pharmaceuticals can be, according to Kalorama Information.  The healthcare market research publisher said that while some may be... [Comments]

Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex

10/20/2014
Richardson, Texas (PRWEB) October 20, 2014 Convey Computer , the leader in hybrid-core computing, today announced that a team from Iowa State University won first place in the 2014 MemoCODE Conference * design contest. Using a Convey HC-2ex, the team’s solution achieved the highest overall performance in the contest—more than 14 times faster than the second place finisher. Experts from... [Comments]

[previous] [next]
(Date:10/16/2014)... human body. Battles are won, lost or sometimes ... stalemate—known as tumor dormancy—can last up to 25 ... is poorly understood. , A new computational ... a Professor of Chemistry at Princeton University, may ... the switch to a malignant state. Published today ...
(Date:10/16/2014)... monocultures can be cultivated efficiently, they are anything ... caused by monoculture cultivation is becoming increasingly evident. ... crop form and are regarded as the sole ... – quite wrongfully, finds Bernhard Schmid, an ecology ... a novel form of agriculture and forestry. After ...
(Date:10/15/2014)... WASHINGTON, N.Y. , Oct. 15, 2014 /PRNewswire/ ... technology solutions for home and community-based care, today ... benefits of implementing Sandata,s Santrax® Electronic Visit Verification™ ... Care Services is a home health company founded ... Texas . The ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
... The Translational Genomics Research Institute (TGen) provides Arizona with ... to the results of an independent analysis released today. ... TGen-led research, a study by the research firm Tripp ... to $321.3 million by 2025. "As we make ...
... September 28, 2009 -- Soybeans contain high ... have antioxidant properties. These molecules can be used ... specific health-beneficial properties and can be used in ... in four forms (α, β, γ, and δ) ...
... biology continue to develop as two of the most ... that the public is almost completely unaware of the ... American adults conducted by Peter D. Hart Research Associates ... 90 percent of Americans think the public should be ...
Cached Biology News:TGen provides Arizona with $77 million in annual economic impact 2TGen provides Arizona with $77 million in annual economic impact 3Eat soybeans to prevent diseases 2Nanotechnology and synthetic biology: What does the American public think? 2
... is an integrated digital microscope and camera ... equipment setup, optical adjustment or software installation. ... technology, COOLSCOPE combines simplicity and advanced technology ... offers simultaneous viewing of a macro image ...
... microscope is described by end-users to be ... the fundamentals of light microscopy and electronic ... footprint, it does not require much space ... busy lab environment. The DM-BA300 combines Motic's ...
... The TUNEL-based assay kit provides complete ... cells for convenient detection of DNA ... sections. The incorporation of BrdU in ... biotinylated or digoxigenylated methods. Results can ...
... ergonomic microscopes are now available in digital ... DM-BA200 comes packed with Motic's patented Colour ... plug and play digital image capture head. ... a reversed quadruple nosepiece, deliver high quality ...
Biology Products:
(Date:10/20/2014)... Mapp Biopharmaceutical,s valiant effort to produce ... fight the Ebola outbreak will make the public ... of pharmaceuticals can be, according to Kalorama Information.  ... some may be taken aback by the three-month ... knowledge are well aware of the complex issues ...
(Date:10/20/2014)... Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... brings Q3 orders to $5.8 million and provides a good start ... North America and one in the ... new projects at record levels," said Peter Bruijns , President ... the end of Q3 than they have been for any complete ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
(Date:10/20/2014)... 2014 Local veterinary surgeon, Dr. Tim ... study of donor stem cells for dogs with osteoarthritis. ... and has performed clinical stem cell therapy for 7 ... determine if a single injection of donor stem cells ... reduce pain and inflammation in the treated joints. ...
Breaking Biology Technology:Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Oct. 30 Cephalon, Inc. (Nasdaq:,CEPH) today announced that ... held on,November 5, 2008, will be webcast live on ... ., Cephalon,s senior management will review the company,s ... will be delivered on Wednesday, November 5, 2008 beginning ...
... - Cytochroma today announced the,appointment of Ulrik Spork to ... on the Company,s Board and replaces Dr. Soren Schifter,who ... remains unchanged at,six members., "We are very pleased ... to drawing on his expertise and experiences as we ...
... Discuss Continued Expansion of DXL(TM) Patent Protection at ... 7th Annual BIO ... InNexus,Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS;, http://www.ixsbio.com ... antibodies based on its Dynamic Cross Linking,(DXL(TM)) technology, announced today ...
Cached Biology Technology:Cephalon, Inc. to Webcast Analyst Day 2Cephalon, Inc. to Webcast Analyst Day 3InNexus Biotechnology Receives Patent Grants in Europe 2